296 related articles for article (PubMed ID: 20410056)
21. Palliation of malignant intestinal obstruction using octreotide.
Khoo D; Hall E; Motson R; Riley J; Denman K; Waxman J
Eur J Cancer; 1994; 30A(1):28-30. PubMed ID: 7511400
[TBL] [Abstract][Full Text] [Related]
22. The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results.
Ripamonti C; Panzeri C; Groff L; Galeazzi G; Boffi R
Tumori; 2001; 87(1):1-9. PubMed ID: 11669548
[TBL] [Abstract][Full Text] [Related]
23. [Effective made of octreotide intravenous administration for malignant gastrointestinal obstruction in terminal cancer patients].
Tanimura K; Onda S; Mitsunobu M
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1991-3. PubMed ID: 20948271
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of granisetron in the antiemetic control of nonsurgical intestinal obstruction in advanced cancer: a phase II clinical trial.
Tuca A; Roca R; Sala C; Porta J; Serrano G; González-Barboteo J; Gómez-Batiste X
J Pain Symptom Manage; 2009 Feb; 37(2):259-70. PubMed ID: 18789638
[TBL] [Abstract][Full Text] [Related]
25. Aggressive pharmacological treatment for reversing malignant bowel obstruction.
Mercadante S; Ferrera P; Villari P; Marrazzo A
J Pain Symptom Manage; 2004 Oct; 28(4):412-6. PubMed ID: 15471659
[TBL] [Abstract][Full Text] [Related]
26. Nausea and vomiting in advanced cancer.
Ang SK; Shoemaker LK; Davis MP
Am J Hosp Palliat Care; 2010 May; 27(3):219-25. PubMed ID: 20197557
[TBL] [Abstract][Full Text] [Related]
27. Successful palliation with octreotide of a neuroendocrine syndrome from malignant melanoma.
Jahng AW; Liao SS
J Pain Symptom Manage; 2006 Aug; 32(2):191-5. PubMed ID: 16877188
[TBL] [Abstract][Full Text] [Related]
28. Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer.
Peng X; Wang P; Li S; Zhang G; Hu S
World J Surg Oncol; 2015 Feb; 13():50. PubMed ID: 25889313
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of malignant intestinal obstruction. A prospective study over 80 cases].
Arvieux C; Laval G; Mestrallet JP; Stefani L; Villard ML; Cardin N
Ann Chir; 2005 Sep; 130(8):470-6. PubMed ID: 16084483
[TBL] [Abstract][Full Text] [Related]
30. Role of corticosteroids in palliative care.
Shih A; Jackson KC
J Pain Palliat Care Pharmacother; 2007; 21(4):69-76. PubMed ID: 18032321
[TBL] [Abstract][Full Text] [Related]
31. Intestinal obstruction.
Baines MJ
Cancer Surv; 1994; 21():147-56. PubMed ID: 8564990
[TBL] [Abstract][Full Text] [Related]
32. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
33. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
Jeremić B
Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
[TBL] [Abstract][Full Text] [Related]
34. The role of octreotide in malignant bowel obstruction.
Krammer LM
Oncol Nurs Forum; 1999 Jun; 26(5):831-2. PubMed ID: 10382174
[No Abstract] [Full Text] [Related]
35. The management of nausea and vomiting in palliative care.
Thompson I
Nurs Stand; 2004 Nov 3-9; 19(8):46-53; quiz 54. PubMed ID: 15552468
[TBL] [Abstract][Full Text] [Related]
36. [Nasea injection in the prophylaxis of gastrointestinal reaction induced by chemotherapeutic agents].
Zhang P; Feng F; He Y
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):70-3. PubMed ID: 11776606
[TBL] [Abstract][Full Text] [Related]
37. [Application of sandostatin in malignant bowel obstruction].
Li J; Jing ML; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):479-81. PubMed ID: 17851794
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide.
McCaffrey N; Asser T; Fazekas B; Muircroft W; Agar M; Clark K; Eckermann S; Lee J; Joshi R; Allcroft P; Sheehan C; Currow DC
BMC Cancer; 2020 Oct; 20(1):1050. PubMed ID: 33129304
[TBL] [Abstract][Full Text] [Related]
39. [Symptomatic alleviation of gastrointestinal symptoms].
Baekke J; Meisner S; Bentsen HH
Ugeskr Laeger; 2007 Oct; 169(44):3759-62. PubMed ID: 18028844
[TBL] [Abstract][Full Text] [Related]
40. [A case of successful treatment using octreotide acetate for occlusive ileus in terminal stage cancer].
Yoshioka S; Tsujie M; Ebisui C; Okubo K; Akitake H; Otsuka M; Maekawa T; Hama N; Kashiwazaki M; Taniguchi M; Konishi M; Fujimoto T
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2266-8. PubMed ID: 20037391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
